Peri-Implant Soft Tissue and Health

NCT07564687 | Completed

• 1 other identifier: BAIBU-DH-TS-07
• Study Type: observational
• Target: 272
• Locations: 1 country
• Sites: 1

Brief Summary

Implant patients who applied to Bolu Abant İzzet Baysal University provided anamnesis. The study included 165 people with 272 implants. The study includes implants that satisfied the inclusion criteria. Plaque index (PI) \[13\], gingival index (GI) \[14\], bleeding on probing (BOP) \[15\], periodontal pocket depth (PPD), clinical attachment level (CAL), gingival recession (GR), GP, GT, and KTW were all assessed in every implant patient. The presence of peri-implant mucositis or peri-implant health was assessed using the collected indices and radiographs. The patients were split into two groups: those with peri-implant mucositis (136 implants) and those with peri-implant health (136 implants). We investigated the relationships between each parameter and periodontal health.

Conditions

Peri Implant Mucositis

Keywords

Dental Implants; Gingiva; Peri-implant tissue

Outcome Measures

Primary Outcomes (1)

• Gingival phenotype

  If the probe was visible when placed in the sulcus, gingiva was classified as thin (≤1 mm), and if the reflection of the probe was not visible, it was classified as thick (\> 1 mm).

  Baseline

Secondary Outcomes (8)

• Periodontal pocket depth

  Baseline

• Bleeding on probing

  Baseline

• Plaque index

  Baseline

• Gingival index

  Baseline

• Clinical attachment level

  Baseline

Study Arms (2)

Peri-implant mucositis

In the absence of bone loss, peri-implant mucositis refers to inflammation of the mucosa surrounding endosseous tissue

Other: Implant

Periodontal health

Peri-implant health is characterized by the absence of erythema, bleeding on probing, swelling, and suppuration, and is synonymous with implant success

Other: Implant

Interventions

Implant OTHER

The classification of peri-implant diseases is based on clinical and radiographic criteria, distinguishing between peri-implant mucositis and peri-implantitis according to the presence of inflammation and bone loss.

Peri-implant mucositis; Periodontal health

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who have received implants

You may qualify if:

• Patients aged 18-65 years who were systemically healthy, had a controlled medical conditions, and had fixed prostheses on the implants for at least 1 year following functional prosthetic loading of the dental implants.

You may not qualify if:

• Individuals with bruxism; those who smoke, were pregnant, or were breastfeeding; those who used anti-inflammatory drugs, immunosuppressants, or medications affecting the mucosa and bone; those who had undergone peri-implant disease treatment after implant placement; and those with residual cement residue and peri-implantitis related to prosthesis design or incorrectly placed implants.

Sponsors & Collaborators

• Tuğba ŞAHİN: lead

Study Sites (1)

Bolu Abant İzzet Baysal University

Bolu, Turkey, 14300, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Drug Implants

Intervention Hierarchy (Ancestors)

Delayed-Action Preparations; Dosage Forms; Pharmaceutical Preparations

Study Officials

• TUGBA SAHIN

  Abant Izzet Baysal University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Assistant professor

Study Record Dates

• First Submitted: April 27, 2026
• First Posted: May 4, 2026
• Study Start: June 11, 2024
• Primary Completion: March 2, 2026
• Study Completion: March 3, 2026
• Last Updated: May 4, 2026

Record last verified: 2026-04

Locations

TU (1)